Results 11 to 20 of about 7,233 (216)

«Como si tocara el piano». Narrativas y procesos asistenciales de la enfermedad de Huntington en Italia [PDF]

open access: yesAntropólogos Iberoamericanos en Red, 2020
Este trabajo tiene el objetivo de explorar la experiencia vivida por los cuidadores de enfermos de Huntington y profundizar la relación con los profesionales a partir del análisis etnográfico de un grupo de cuidadores que asisten a un grupo de autoayuda ...
Nicoletta Castagna
doaj   +1 more source

Early prediction of Alzheimer's disease and related dementias using real‐world electronic health records

open access: yesAlzheimer's &Dementia, Volume 19, Issue 8, Page 3506-3518, August 2023., 2023
Abstract Introduction This study aims to explore machine learning (ML) methods for early prediction of Alzheimer's disease (AD) and related dementias (ADRD) using the real‐world electronic health records (EHRs). Methods A total of 23,835 ADRD and 1,038,643 control patients were identified from the OneFlorida+ Research Consortium.
Qian Li   +16 more
wiley   +1 more source

Modified Periodic Acid‐Schiff (PAS) Is an Alternative to Safranin O for Discriminating Bone–Cartilage Interfaces

open access: yesJBMR Plus, Volume 7, Issue 6, June 2023., 2023
Safranin O is a commonly used dye that binds to proteoglycans in cartilage and is routinely used to assess growth plate dynamics and/or fracture repair at bone–cartilage interfaces. Decalcification and processing methods can deplete proteoglycans, rendering weak or absent safranin O staining with indiscriminate cartilage boundaries.
Kelsey M Kjosness   +2 more
wiley   +1 more source

The role of STING signaling in central nervous system infection and neuroinflammatory disease

open access: yesWIREs Mechanisms of Disease, Volume 15, Issue 3, May/June 2023., 2023
Following brain injury, cGAS‐STING signaling in resident microglia is activated, producing interferons and chemokines that result in the infilitration of peripheral immune cells. Abstract The cyclic guanosine monophosphate–adenosine monophosphate (GMP‐AMP) synthase‐Stimulator of Interferon Genes (cGAS‐STING) pathway is a critical innate immune ...
Lauren E. Fritsch   +2 more
wiley   +1 more source

Expanded and Independent Spanish Validation of the MDS‐Non Motor Rating Scale

open access: yesMovement Disorders Clinical Practice, Volume 10, Issue 4, Page 586-595, April 2023., 2023
Abstract Background The Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS) assess the severity and disability caused by non‐motor symptoms (NMS) in Parkinson's disease (PD). Objective This article encapsulates the formal process for completing this program and the data on the first officially approved non‐English version of the MDS ...
Esther Cubo   +44 more
wiley   +1 more source

The manifold role of octapeptide repeats in prion protein assembly

open access: yesPeptide Science, Volume 115, Issue 2, March 2023., 2023
Abstract Prion protein misfolding is associated with fatal neurodegenerative disorders such as kuru, Creutzfeldt–Jakob disease, and several animal encephalopathies. While the C‐terminal 106–126 peptide has been well studied for its role in prion replication and toxicity, the octapeptide repeat (OPR) sequence found within the N‐terminal domain has been ...
Amy H. Guadagno, Scott H. Medina
wiley   +1 more source

La enfermedad de Huntington en Asturias. 1996 - 2008

open access: yes, 2014
Antecedentes/Objetivos: La Enfermedad de Huntington es una dramática enfermedad neurológica afectada por un considerable determinismo biológico y una evolución desfavorable que conlleva una gran carga de enfermedad y una afectación en generaciones anteriores y posteriores a los casos que puede ser evitada con consejo genético.
Margolles, Pedro, Margolles, Mario
  +5 more sources

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

open access: yesMovement Disorders, Volume 38, Issue 2, Page 286-303, February 2023., 2023
Abstract Background As gene‐targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated number of subjects with monogenic PD worldwide are currently represented in the literature and availability of
Eva‐Juliane Vollstedt   +306 more
wiley   +1 more source

Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

open access: yesGlia, Volume 71, Issue 1, Page 103-126, January 2023., 2023
Main Points Endocannabinoids modulate glial cells. Targeting glial cells with endocannabinoids is a therapeutic option in neurological disorders. Efficacious endocannabinoid‐based therapies require analysis of cell‐type and disease‐specific mechanisms.
Ana Bernal‐Chico   +5 more
wiley   +1 more source

Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study

open access: yesEuropean Journal of Neurology, Volume 30, Issue 1, Page 215-223, January 2023., 2023
Abstract Background and purpose Myotonic dystrophy type 1 (DM1) is a hereditary and multisystemic disease that is characterized by heterogeneous manifestations. Although muscular impairment is central to DM1, a premanifest DM1 form has been proposed for those characterized by the absence of muscle signs in precursory phases.
Joana Garmendia   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy